Join the Movement

Let's fix the proposed new trade agreement with Mexico and Canada (USMCA) and work together to lower drug prices for patients. Send a message to your elected representatives now!

Take Action
Poll Results: USMCA Trade Agreement

U.S. voters are concerned that the proposed new trade agreement with Mexico and Canada (USMCA) will negatively impact drug prices and access to generics.

See the Poll Results
Meet Your Industry Peers

Access! 2019 is marching into New Orleans, February 4-6. Bolster your position in the market as a thought leader and network with those shaping the generics and biosimilars industry.

Register Now
Generic Drugs are the Prescription for Savings

More than 9 out of 10 generic drug prescriptions are filled for $20 or less.

View Infographic
Patients Can See Their Savings

For the first time ever, the Association for Accessible Medicines is releasing savings data for 20 common patient conditions.

Learn More
Preserve Patient Access in Trade Agreements

The new trade agreement (USMCA) keeps drug prices high, for longer and creates new barriers to competition from generics and biosimilars. Without action, drug prices will remain out of reach for Americans.

Learn More
Skyrocketing Drug Prices are a Threat to Everyone

Use this infographic to learn how generics and biosimilars are a remedy to sky-high health care costs.

Read Blog

Working to leave a positive impact on...

Industry

We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More

People

We measure our success as an industry by the lives we impact. We work to protect the low cost of current drugs and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More

Society

We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable medicines. Learn More

About Us

The Association for Accessible Medicines, formerly the Generic Pharmaceutical Association, improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Recent Updates

Dec 10, 2018 | Rachel Schwartz

Andrew O’Connor Joins AAM as Manager, State Government Affairs

AAM Statement on Signing of USMCA by President

Nov 30, 2018 | Rachel Schwartz

AAM Statement on Signing of USMCA by President

AAM's Strategic Priorities for 2019

Nov 28, 2018 | Jewel Smith

You’re Invited! AAM Strategic Priorities Planning for the New Year

Generics and Biosimilars

Nov 27, 2018 | David Gaugh

Preliminary Recommendations for Addressing Drug Shortages

Video

Nov 19, 2018 | Erica Klinger

AAM CEO Chip Davis: Midterm Elections Will Impact Your Business

Preserve Patient Access in USMCA

Nov 14, 2018 | Rachel Schwartz

Poll Results: Americans’ Attitudes on U.S. Trade Policy and Drug Pricing